Clinical Trial Update: Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of pegfilgrastim to prevent chemotherapy-induced neutropenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Conditions: Neutropenia | Phase 2 | Status: UNKNOWN